Ventricular catheters market seen reaching 8.7% growth by 2030

The Business Research Company says the global ventricular catheters market will grow from $0.83 billion in 2026 to $1.17 billion by 2030, driven by rising neurosurgical procedures, neurological disease burden and demand for minimally invasive care. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Ventricular catheters are used to drain cerebrospinal fluid and monitor intracranial pressure in patients with hydrocephalus, traumatic brain injury and intracranial hemorrhage. - Rising demand for neurosurgical procedures supports more use of these devices in hospitals and critical care settings. - The market outlook points to more adoption of minimally invasive, smart and infection-reduction technologies in neurological care.

What happened: - The Business Research Company released its "Ventricular Catheters Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035." - The report values the ventricular catheters market at $0.83 billion in 2026. - The report forecasts the market will reach $1.17 billion by 2030. - The forecast implies a 8.7% compound annual growth rate through 2030. - The market was valued at $0.77 billion in 2025. - North America held the largest share of the market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - Growth in 2026 is linked to higher hydrocephalus and neurological disorder incidence, more traumatic brain injury cases, wider use of neurosurgical procedures in hospitals, growth in neurocritical care facilities and greater awareness of intracranial pressure management. - The report cites future growth drivers including advances in neuroimaging and neurosurgical techniques, more interest in minimally invasive devices, higher investment in neurocritical care units, an aging population and wider use of smart, sensor-integrated technologies. - Key trends include more use of antibiotic-impregnated catheters to reduce infections. - The report also flags growing demand for minimally invasive cerebrospinal fluid drainage systems in critical care. - Smart pressure monitoring catheters are gaining use for real-time intracranial pressure tracking. - Advanced biomaterial-based catheters are in development to improve biocompatibility and patient outcomes. - Pediatric and neonatal ventricular access devices are seeing greater use in specialized neurological care. - Ventricular catheters are sterile, flexible tubes inserted into the brain’s ventricular system for fluid drainage, pressure reduction or monitoring. - The devices are widely used in neurosurgery for hydrocephalus, traumatic brain injuries and intracranial hemorrhages. - The market analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, and the Middle East and Africa.

Between the lines: - The market forecast suggests vendors are competing on infection prevention, pressure monitoring and ease of use, not just drainage function. - The emphasis on smart and sensor-based devices signals a shift toward more data-driven neurological care. - A reported increase in brain tumor neurosurgical procedures at Great Ormond Street Hospital, from 121 cases in April 2022-March 2023 to 126 cases in April 2023-March 2024, illustrates the surgical volume trend supporting demand.

What's next: - The report expects continued expansion through 2030 as hospitals invest more in neurocritical care and minimally invasive neurosurgery. - Adoption of antibiotic-coated, biomaterial and sensor-enabled catheters is likely to shape product development. - Regional growth is expected to remain strongest in Asia-Pacific as global demand broadens beyond North America.

The bottom line: - Ventricular catheters are moving from a niche neurosurgical tool to a growing part of critical neurological care, with the market on track for steady expansion through 2030.